XENLETA

Peak

lefamulin acetate

Zai Lab
NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Aug 2019
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Jun 14, 2036
125 months away
Patent Expiry
Jun 14, 2036
Exclusivity Expiry
Aug 19, 2029

Patent Records (3)

Patent #ExpiryTypeUse Code
8153689
Mar 19, 2028
SubstanceProduct
—
8071643
Mar 25, 2033
SubstanceProduct
—
12121582
Jun 14, 2036
Product
—
Company
Zai Lab
Zai Lab
CA - South SF
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers